Request page removalAbout Kiran Shaw
Kiran Shaw is an angel investor and a board member based out of Bengaluru, India. They did their Masters from UniMelb in 1975. Their journey in the startup ecosystem started in 2013 through Embrace Global. As an angel investor, Kiran Shaw has a portfolio of 9 companies, focusing primarily on sectors like Life Sciences, Enterprise Applications and 5 more sectors. They invest in companies across India and United States. Their most notable investments include companies like Strand Life Sciences and Immuneel. Kiran Shaw is currently serving as a board member at Immuneel, Syngene and 1 more company.
Key Metrics
Location
Bengaluru, India
Investment Portfolio
Top sectors of Investment
Top locations of Investment
Contact Details
Kiran Shaw's Investments
Kiran Shaw has invested in 9 companies. Their most recent investment was in Immuneel (Series B Round) on Jun 08, 2026. Their investments are primarily in Life Sciences, Enterprise Applications and 5 more sectors. Their investment portfolio include companies in India and United States.Here is the list of recent investments by Kiran Shaw:
Date | Company | Round | Round Amount | Co-Investors |
|---|---|---|---|---|
Jun 08, 2026 | Series B | $10.5M | ||
Jan 03, 2023 | Seed | $568K | and 6 more | |
Dec 01, 2021 | Series B | $18M | ||
Aug 28, 2020 | Angel | Undisclosed | - |
Want to explore profiles similar to Kiran Shaw?
Let us walk you through our investor database and other offerings.
Let us walk you through our investor database and other offerings.
Kiran Shaw's Portfolio Exits
Kiran Shaw has 2 Portfolio Exits namely Strand Life Sciences and Glympse Bio.
Here are the details of all portfolio exits by Kiran Shaw:
Company | Description | Location | Total Funding | Founded Year | Exit Type | Exit Date |
|---|---|---|---|---|---|---|
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery | Bengaluru (India) | $34.9M | 2000 | Acquisition | Sep 03, 2021 | |
Provider of noninvasive and predictive monitoring of multiple human diseases | Cambridge (United States) | $79.4M | 2015 | Acquisition | Aug 09, 2023 |
Kiran Shaw's Board Memberships
Kiran Shaw has 3 current board memberships including Immuneel and Syngene.Here is the list of top board memberships by Kiran Shaw:
Company | Description | Total Funding | Current Stage | Membership Status | Appointment Date | Cessation Date |
|---|---|---|---|---|---|---|
Developer of T-cell therapies for the treatment of cancer | $49.8M | Series B | CURRENT | Dec 20, 2018 | - | |
Provider of contract research and manufacturing services for both small molecules and biologics | $85.9M | Public | CURRENT | Nov 18, 1993 | - |
Kiran Shaw's Top News
•
Glympse Bio, Inc. Raises $22m Series A FinancingBusiness Wire•Oct 09, 2018•Glympse Bio, Polaris Partners, Arch Venture Partners, CRV and 8 others
•
Shekhar Gupta’s The Print raises funds from Ratan Tata, Nandan Nilekani, Uday KotakMint•May 22, 2017•ThePrint, N. R. Narayana Murthy, Nandan Mohan Nilekani, Ratan Naval Tata and 10 others
•
Shekhar Gupta’s The Print raises funds from Ratan Tata, Nandan Nilekani, Uday KotakMint•May 22, 2017•ThePrint, Ratan Naval Tata, Uday Kotak, Kiran Mazumdar Shaw and 9 others
FAQs about Kiran Shaw
Recently updated other profiles
